Pinholes Lead to Fisher and Paykel Breathing Circuit Recall

|

A Class I recall has been initiated for Fisher and Paykel reusable breathing circuits, due to a risk that the tubes may contain pinholes that could lead to a loss of oxygen and patient death. 

The Reusable Breathing Circuit recall was announced by the FDA on January 3, after Fisher and Paykel Healthcare issued an Urgent Medical Device Recall letter in November to inform customers that the reusable breathing tubes may possess pinholes. This may cause gas leaks in the breathing system, resulting in a loss of pressure for the intended ventilation therapy.

The FDA has determined that the severity of the problem merited a Class I recall status, suggesting that continued use of the product poses a reasonable probability of serious health consequences or death.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The Reusable Breathing Circuits are non-heated breathing circuits intended for oxygen therapy delivery for adult patients. The breathing circuits were manufactured by Fisher and Paykel of Irvine, California between August 2011 and October 2011 and distributed between April 6,2012 through September 27, 2012. The recalled breathing circuits have model number 900MR068 and lot numbers 110810 and 111020.

The manufacturer’s Urgent Medical Device Recall letter to customers included a Product Recall Response Form that should be filled out after examining their inventory and destroying and discarding any affected circuits in their possession. Replacement circuits will be provided to customers upon receipt of the Product Recall Response form indicating the number of replacements required. Consumers may also contact Fisher and Paykel Healthcare at 1-800-446-3908, ext 5003.

Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.
A group of plaintiffs are asking a panel of federal judges to consolidate all Lyft lawsuits involving driver sexual assaults against passengers before one judge as part of a Lyft MDL.
Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation.